<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zheng P</submitter><funding>Beckman Coulter Foundation</funding><funding>NIBIB NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>National Institute of Biomedical Imaging and Bioengineering</funding><pagination>e2200090</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9302383</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(18)</volume><pubmed_abstract>Small molecules play a pivotal role in regulating physiological processes and serve as biomarkers to uncover pathological conditions and the effects of therapeutic treatments. However, it remains a significant challenge to detect small molecules given the size as compared to macromolecules. Recently, the newly emerging plasmonic immunoassays based on surface-enhanced Raman scattering (SERS) offer great promise to deliver extraordinary sensitivity. Nevertheless, they are limited by the intrinsic SERS intensity fluctuations associated with the SERS uncertainty principle. The single transducer that relies on the intensity change is also prone to false signals. Additionally, the prevailing sandwich immunoassay format proves less effective towards detecting small molecules. To circumvent these </pubmed_abstract><journal>Small (Weinheim an der Bergstrasse, Germany)</journal><pubmed_title>A Dual-Modal Single-Antibody Plasmonic Spectro-Immunoassay for Detection of Small Molecules.</pubmed_title><pmcid>PMC9302383</pmcid><funding_grant_id>DP2 GM128198</funding_grant_id><funding_grant_id>2-P41-EB015871-31</funding_grant_id><funding_grant_id>DP2GM128198</funding_grant_id><funding_grant_id>P41 EB015871</funding_grant_id><funding_grant_id>2‐P41‐EB015871−31</funding_grant_id><pubmed_authors>Barman I</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Hanson WA</pubmed_authors><pubmed_authors>Raj P</pubmed_authors><pubmed_authors>Zheng P</pubmed_authors><pubmed_authors>Szabo M</pubmed_authors><pubmed_authors>Mizutani T</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Dual-Modal Single-Antibody Plasmonic Spectro-Immunoassay for Detection of Small Molecules.</name><description>Small molecules play a pivotal role in regulating physiological processes and serve as biomarkers to uncover pathological conditions and the effects of therapeutic treatments. However, it remains a significant challenge to detect small molecules given the size as compared to macromolecules. Recently, the newly emerging plasmonic immunoassays based on surface-enhanced Raman scattering (SERS) offer great promise to deliver extraordinary sensitivity. Nevertheless, they are limited by the intrinsic SERS intensity fluctuations associated with the SERS uncertainty principle. The single transducer that relies on the intensity change is also prone to false signals. Additionally, the prevailing sandwich immunoassay format proves less effective towards detecting small molecules. To circumvent these </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-19T08:10:04.456Z</modification><creation>2025-04-19T08:10:04.456Z</creation></dates><accession>S-EPMC9302383</accession><cross_references><pubmed>35373504</pubmed><doi>10.1002/smll.202200090</doi></cross_references></HashMap>